KF
IMRX icon

Kelsey Financial’s Immuneering IMRX Stock Holding History

Kelsey Financial’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82K Buy
16,425
+1,326
+9% +$6.71K 0.06% 64
2026
Q1 		$79.6K Buy
15,099
+1,000
+7% +$5.13K 0.07% 61
2025
Q4 		$92.8K Buy
+14,099
New +$90.5K 0.08% 60

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Kelsey Financial's IMRX Position: Q2 2026 in Review

Kelsey Financial increased its Immuneering (IMRX) stake by 8.8% in Q2 2026, buying an estimated $6.71K and bringing the position to 16,425 shares worth $82K. The position accounts for 0.06% of the portfolio, ranked #64.

Kelsey Financial first reported a position in IMRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $92.8K in Q4 2025. 112 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Kelsey Financial held 16,425 shares of Immuneering worth $82K as of Q2 2026.
  • Kelsey Financial bought 1,326 Immuneering shares in Q2 2026, an estimated $6.71K.
  • Immuneering made up 0.06% of Kelsey Financial's portfolio in Q2 2026, its #64 holding.
  • Kelsey Financial first reported a position in Immuneering in Q4 2025 and has held it in 3 quarters since.
  • Kelsey Financial's Immuneering position peaked at $92.8K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Kelsey Financial's 13F filing for Q2 2026, filed 10 Aug 2026.